Three reasons why Life Sciences firms are active data rooms users

Jun 7, 2011 - by Elizabeth Caley

Tightening FDA approval standards are pushing Life Sciences firms to make even further investments in technologies that support secure document sharing with multiple parties.  At Firmex, our life sciences clients continue to open more data rooms and use more bandwidth and storage than any other industry segment.
The Life Sciences industry includes organizations involved in pharmaceuticals, biotechnology, medical devices and clinical research, all companies with highly capital intensive development pipelines.  To be successful, these firms must fill their pipelines with a steady stream of potential products from a range of R&D efforts, knowing that only a few will become commercial successes. 

We asked our Life Sciences clients to explain why they are such active users of data rooms, and here is what they told us: 

Health Care M&A Trends and Drivers

Mar 31, 2012 - by David Jasmund

We often highlight articles from our customers that would be interesting and relevant to the Firmex community. Enjoy this in-depth report by David Jasmund of PCE Companies, on Health Care M&A Trends and Drivers.

Promising Signs for Life Sciences M&A Activity in April

May 3, 2012 - by Debbie Stephenson

April proved to be a big month for M&A activity in the Life Sciences industry as companies announced more than $29 billion in agreed upon transactions, the bulk of which occurred during the final week. This stood in stark contrast to the IPO market, which saw no completed Life Sciences offerings in U.S. markets during the month.